Showing results (271-280 of 648) with videos related to

Sort By:
Pageof 65
Hemasphere|January 16, 2025
Impact of myelodysplasia-related and additional gene mutations in intensively treated patients with NPM1-mutated AMLSibylle Cocciardi, Maral Saadati, Nina Weiß, et al.
Hemasphere|February 3, 2025
Diagnosis and treatment of AML in the context of WHO and ICC 2022 classifications: Divergent nomenclature converges on common therapiesUwe Platzbecker, Richard A Larson, Sandeep Gurbuxani
Hemasphere|December 12, 2024
Time-restricted versus standard-duration immunosuppression after allogeneic hematopoietic stem cell transplantation: Results of the prospective randomized HOVON-96 trialAnnoek E C Broers, Ellen Meijer, Bronno van der Holt, et al.
Hemasphere|December 4, 2023
CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep?Candida Vitale, Valentina Griggio, Francesca Perutelli, et al.
Hemasphere|November 29, 2023
Integration of Transcriptomic Features to Improve Prognosis Prediction of Pediatric Acute Myeloid Leukemia With KMT2A RearrangementJun Li, Suyu Zong, Yang Wan, et al.
Hemasphere|November 29, 2023
CAR-T Cell Therapy for Classical Hodgkin LymphomaMikalai Katsin, Dmitri Dormeshkin, Alexander Meleshko, et al.
Hemasphere|March 15, 2024
Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia-positive lymphoid leukemia to tyrosine kinase inhibitorsLukasz Komorowski, Agnieszka Dabkowska, Joanna Madzio, et al.
Hemasphere|March 21, 2024
Chimeric antigen receptor-T cell therapy shows similar efficacy and toxicity in patients with diffuse large B-cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort studyPhilipp Berning, Evgenii Shumilov, Markus Maulhardt, et al.
Hemasphere|March 11, 2024
Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemiaAndré Almeida, Sara T'Sas, Luca Pagliaro, et al.
Hemasphere|September 26, 2024
NUP98 oncofusions in myeloid malignancies: An update on molecular mechanisms and therapeutic opportunitiesMilad Rasouli, Selina Troester, Florian Grebien, et al.
Pageof 65